Periodic Reporting for period 3 - AML-VACCiN (Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia)

AML-VACCiN is an international consortium that aims at developing a novel treatment strategy for the rare disease acute myeoloid leukaemia (AML). The main objective of AML-VACCiN is to test the potential of a novel vaccine treatment to prevent relapse in post-remission AML...